cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.8862140
title: BOT vegetation by functional group

description: Vegetation cover, by functional group, in five boma occupation treatments (0,4,7,14, and 28 days), each replicated five times, for multiple time periods over three years. <br>See data file and Veblen, K.E. and L.M. Porensky. Thresholds are in the eye of the beholder: plants and wildlife respond differently to short-term cattle corrals. Ecological Applications, for further details.
DOI: 10.6084/m9.figshare.8862143.v1
title: BOT vegetation by species

description: Vegetation cover, by species, in five boma occupation treatments (0,4,7,14, and 28 days), each replicated five times, during pre-treatment, year 2 and year 3 time periods.<br>See data file and Veblen, K.E. and L.M. Porensky. Thresholds are in the eye of the beholder: plants and wildlife respond differently to short-term cattle corrals. Ecological Applications, for further details.
DOI: 10.6084/m9.figshare.8862152.v1
title: Table S2. Summary of 36 possible EPAS1 diplotypes and their frequency in cases and controls.

description: Table S2. Summary of 36 possible EPAS1 diplotypes and their frequency in cases and controls.
DOI: 10.6084/m9.figshare.8862140.v1
title: BOT vegetation by functional group

description: Vegetation cover, by functional group, in five boma occupation treatments (0,4,7,14, and 28 days), each replicated five times, for multiple time periods over three years. <br>See data file and Veblen, K.E. and L.M. Porensky. Thresholds are in the eye of the beholder: plants and wildlife respond differently to short-term cattle corrals. Ecological Applications, for further details.
DOI: 10.6084/m9.figshare.8862089
title: Table S1. Metadata and phased EPAS1 diplotypes for 102 case-control pairs.

description: Table S1. Metadata and phased EPAS1 diplotypes for 102 case-control pairs.
DOI: 10.6084/m9.figshare.8862089.v1
title: Table S1. Metadata and phased EPAS1 diplotypes for 102 case-control pairs.

description: Table S1. Metadata and phased EPAS1 diplotypes for 102 case-control pairs.
DOI: 10.6084/m9.figshare.8861750
title: metagenomic

description: metagenomic
DOI: 10.6084/m9.figshare.8861750.v1
title: metagenomic

description: metagenomic
DOI: 10.6084/m9.figshare.8860784
title: metabolomic

description: Metabolomic
DOI: 10.6084/m9.figshare.8860784.v2
title: metabolomic

description: Metabolomic
DOI: 10.6084/m9.figshare.8859662
title: Datas.xlsx

description: Please, find attached the raw data of our figures<br>
DOI: 10.6084/m9.figshare.8859626
title: Figure 2 - data

description: Immunocytochemistry quantification of OCT4/RGECO expression in AAVS1-targeted hiPSC clones across five different genotypes. PCR gels to determine biallelic targeting in hiPSC clones. Immunocytochemistry quantification of cardiac alpha actinin/RGECO expression in a subset of hiPSC-CM clones
DOI: 10.6084/m9.figshare.8859623
title: BOT dung counts

description: Number of dung piles in five boma occupation treatments (0,4,7,14, and 28 days), each replicated five times, for multiple time periods over three years. <br> See data file and Veblen, K.E. and L.M. Porensky. Thresholds are in the eye of the beholder: plants and wildlife respond differently to short-term cattle corrals. Ecological Applications, for further details.
DOI: 10.6084/m9.figshare.8859662.v2
title: Datas.xlsx

description: Please, find attached the raw data of our figures<br>
DOI: 10.6084/m9.figshare.8859623.v1
title: BOT dung counts

description: Number of dung piles in five boma occupation treatments (0,4,7,14, and 28 days), each replicated five times, for multiple time periods over three years. <br> See data file and Veblen, K.E. and L.M. Porensky. Thresholds are in the eye of the beholder: plants and wildlife respond differently to short-term cattle corrals. Ecological Applications, for further details.
DOI: 10.6084/m9.figshare.8859626.v2
title: Figure 2 - data

description: Immunocytochemistry quantification of OCT4/RGECO expression in AAVS1-targeted hiPSC clones across five different genotypes. PCR gels to determine biallelic targeting in hiPSC clones. Immunocytochemistry quantification of cardiac alpha actinin/RGECO expression in a subset of hiPSC-CM clones
DOI: 10.6084/m9.figshare.8859626.v1
title: Figure 2 - data

description: Immunocytochemistry quantification of OCT4/RGECO expression in AAVS1-targeted hiPSC clones across five different genotypes. PCR gels to determine biallelic targeting in hiPSC clones. Immunocytochemistry quantification of cardiac alpha actinin/RGECO expression in a subset of hiPSC-CM clones
DOI: 10.6084/m9.figshare.8859662.v1
title: Datas.xlsx

description: Please, find attached the raw data of our figures<br>
DOI: 10.6084/m9.figshare.8859557
title: MMIP Ox Stress Supplemental Tables Revision clean.docx

description: Supplemental data for the report submitted to Journal of Clinical Endocrinology and Metabolism titled "<b>Maternal Exposure to Environmental Disruptors and Sexually-Dimorphic Changes in Maternal and Neonatal Oxidative Stress</b>"<br>
DOI: 10.6084/m9.figshare.8859557.v1
title: MMIP Ox Stress Supplemental Tables Revision clean.docx

description: Supplemental data for the report submitted to Journal of Clinical Endocrinology and Metabolism titled "<b>Maternal Exposure to Environmental Disruptors and Sexually-Dimorphic Changes in Maternal and Neonatal Oxidative Stress</b>"<br>
DOI: 10.6084/m9.figshare.8859503
title: Figure 1 - data

description: PCR integration gels for AAVS1 targeted hiPSC lines. Sequencing chromatograms to confirm integration.
DOI: 10.6084/m9.figshare.8859437
title: Figure 5 - data

description: Representative confocal line scan data and kymographs for an isogenic trio of c.<i>MYH7</i><sup>C9123T</sup> R-GECO1.0 expressing hiPSC-CMs at day 30 and an isogenic pair of c.<i>ACTC1</i><sup>G301A</sup> R-GECO1.0 expressing hiPSC-CMs at day 30. Ca<sup>2+</sup> transient event detection datasets included.
DOI: 10.6084/m9.figshare.8859323
title: Diagnosing type 2 myocardial infarction in clinical routine. A validation study

description: <i>Objective.</i> Since 2010, myocardial infarction (MI) patients reported to the Swedish registry for MI (SWEDEHEART) are routinely classified into MI subtypes. The registry has been used to study the type 2 MI population but the MI-classification in the registry has not previously been validated. The aim of this study was to validate the type 2 MI classification in the registry. <i>Design.</i> A total of 772 patients diagnosed with MI in 2011 and reported to the SWEDEHEART registry were included in the study. All patients were retrospectively classified into MI type 1–5 or myocardial injury by independent reviewers strictly adhering to <i>The Third Universal Definition of MI.</i> This gold standard classification was compared with the classification in the registry. <i>Results.</i> Forty-eight (6.2%) patients were classified as type 2 MI in the registry compared with 93 (12.0%) according to the gold standard classification. A type 2 MI diagnosis was confirmed in 30 out of the 48 type 2 MI patients in the registry (PPV: 62.5%). There was a moderate rate of agreement (κ: 0.43) between the gold standard classification and the classification in SWEDEHEART in deciding a type 2 MI diagnosis. <i>Conclusion.</i> The SWEDEHEART registry agreed moderately with the gold standard in classifying patients with type 2 MI diagnosis. Thus, studies on patients with type 2 MI in the registry should be interpreted with caution. Since the prevalence of type 2 MI is substantially underestimated in SWEDEHEART, the registry should not be used to study the prevalence of type 2 MI.
DOI: 10.25392/leicester.data.8859317
title: validator_2019-07-10.sql.gz

description: MySQL database containing transcript and gene information for use with VariantValidator available at:https://github.com/openvar/variantValidator<br>
DOI: 10.6084/m9.figshare.8859323.v2
title: Diagnosing type 2 myocardial infarction in clinical routine. A validation study

description: <i>Objective.</i> Since 2010, myocardial infarction (MI) patients reported to the Swedish registry for MI (SWEDEHEART) are routinely classified into MI subtypes. The registry has been used to study the type 2 MI population but the MI-classification in the registry has not previously been validated. The aim of this study was to validate the type 2 MI classification in the registry. <i>Design.</i> A total of 772 patients diagnosed with MI in 2011 and reported to the SWEDEHEART registry were included in the study. All patients were retrospectively classified into MI type 1–5 or myocardial injury by independent reviewers strictly adhering to <i>The Third Universal Definition of MI.</i> This gold standard classification was compared with the classification in the registry. <i>Results.</i> Forty-eight (6.2%) patients were classified as type 2 MI in the registry compared with 93 (12.0%) according to the gold standard classification. A type 2 MI diagnosis was confirmed in 30 out of the 48 type 2 MI patients in the registry (PPV: 62.5%). There was a moderate rate of agreement (κ: 0.43) between the gold standard classification and the classification in SWEDEHEART in deciding a type 2 MI diagnosis. <i>Conclusion.</i> The SWEDEHEART registry agreed moderately with the gold standard in classifying patients with type 2 MI diagnosis. Thus, studies on patients with type 2 MI in the registry should be interpreted with caution. Since the prevalence of type 2 MI is substantially underestimated in SWEDEHEART, the registry should not be used to study the prevalence of type 2 MI.
DOI: 10.25392/leicester.data.8859317.v2
title: validator_2019-07-10.sql.gz

description: MySQL database containing transcript and gene information for use with VariantValidator available at:https://github.com/openvar/variantValidator<br>
DOI: 10.6084/m9.figshare.8859302
title: 16S ESVs phyloseq object

description: A R object file (.rds) containing a phyloseq object of UNOISE3 identified 16S exact sequence variants (ESVs) across 15 soil sites in New Zealand.
DOI: 10.25392/leicester.data.8859317.v1
title: validator_2019-07-10.sql.gz

description: MySQL database containing transcript and gene information for use with VariantValidator available at:https://github.com/openvar/variantValidator<br>
DOI: 10.6084/m9.figshare.8859290
title: 97% 16S OTUs phyloseq object

description: A R object file (.rds) containing a phyloseq object of VSEARCH identified 97% identity clustered bacterial 16S OTUs across 15 soil sites in New Zealand.<br>
DOI: 10.6084/m9.figshare.8859290.v1
title: 97% 16S OTUs phyloseq object

description: A R object file (.rds) containing a phyloseq object of VSEARCH identified 97% identity clustered bacterial 16S OTUs across 15 soil sites in New Zealand.<br>
DOI: 10.6084/m9.figshare.8859215
title: 99% rpoB OTU phyloseq object

description: An R object file (.rds) containing a phyloseq object of VSEARCH clustered 99% identity<i> Streptomyces</i> <i>rpoB</i> OTUs from 15 New Zealand soils.<br>
DOI: 10.6084/m9.figshare.8859215.v1
title: 99% rpoB OTU phyloseq object

description: An R object file (.rds) containing a phyloseq object of VSEARCH clustered 99% identity<i> Streptomyces</i> <i>rpoB</i> OTUs from 15 New Zealand soils.<br>
DOI: 10.6084/m9.figshare.8859152
title: ITdataset

description: Dataset for "Inflation targeting in low-income countries: Does IT work?", by Morozumi, Bleaney, and Mumuni, published at Review of Development Economics. ITdataset_1 (for Tables 2,3,and 5 of the paper), ITdataset_2 (Table 4), and ITdataset_3 (Tables 6, 7, 8 and 9)
DOI: 10.6084/m9.figshare.8858987
title: Figure 4 - data

description: Live imaging of mScarlet expression from AAVS1-targeted hiPSCs undergoing haematopoietic or cardiomyocyte differentiation. Raw qPCR data showing a progressive decline in HOXA9 expression during both of these differentiations.
DOI: 10.6084/m9.figshare.8858951
title: New insights into the roles of the <i>FOXO3</i> and <i>P27Kip1</i> genes in signaling pathways

description: <b>Background:</b> The forkhead box O3 (FOXO3) and p27Kip1 are two important genes in breast cancer progression. In the present study we analyzed the effect of simultaneous FOXO3 silencing and p27Kip1 activation on breast cancer cell survival and the potential targets of these changes in cancer molecular pathways. <b>Materials and methods:</b> The present study involved the cloning of <i>FOXO3a</i> shRNA and <i>p27Kip1</i> genes under the control of the bidirectional survivin promoter to down- and up-regulate <i>FOXO3</i> and <i>p27Kip1</i> genes, respectively. After transfection of the recombinant expression vector into the breast cancer cell line, the inhibition of cell growth was assessed by MTS and flow cytometry assays. Following the extraction of total mRNA and protein, the expression of target genes was evaluated by qPCR and Western blotting in both treated and untreated cell lines. Then, the downstream protein responses were examined by 2 D electrophoresis. The differentially expressed proteins were also identified by mass spectrometry. <b>Results:</b> Rates of cell proliferation were significantly inhibited in the transfected cell line 72 h post-transfection. Proteomic profiling of the cell line resulted in the identification of seven novel protein markers in breast cancer responsive to these changes in expression of <i>FOXO3</i> and <i>p27Kip1</i>. The changes in expression of these markers suggested that certain signaling pathways contribute to the development of breast cancer. <b>Conclusion:</b> Simultaneous silencing of <i>FOXO3</i> and activation of <i>p27Kip1</i> in MDA-MB-231 cells caused alterations in the expression level of several genes involved in apoptosis, cell proliferation, cell cycle control, tissue invasion, drug resistance, and metastasis. It seems that the identified genes might serve as useful biomarkers for breast cancer.
DOI: 10.6084/m9.figshare.8858987.v1
title: Figure 4 - data

description: Live imaging of mScarlet expression from AAVS1-targeted hiPSCs undergoing haematopoietic or cardiomyocyte differentiation. Raw qPCR data showing a progressive decline in HOXA9 expression during both of these differentiations.
DOI: 10.6084/m9.figshare.8859152.v1
title: ITdataset.dta

description: Dataset for a paper submitted to Review of Development Economics (titled Inflation targeting in low-income countries: Does IT work?)
DOI: 10.6084/m9.figshare.8858948
title: The Effects of Recalling Positive and Negative Contacts on Linguistic Discrimination towards Migrant People

description: The present data were used to test whether varying the sequential position in which majority members recall positive and negative contacts with migrants affects the linguistic representations – in terms of abstraction and valence – embedded in their descriptions of encounters.
DOI: 10.6084/m9.figshare.8858948.v1
title: The Effects of Recalling Positive and Negative Contacts on Linguistic Discrimination towards Migrant People

description: The present data were used to test whether varying the sequential position in which majority members recall positive and negative contacts with migrants affects the linguistic representations – in terms of abstraction and valence – embedded in their descriptions of encounters.
DOI: 10.6084/m9.figshare.8858951.v2
title: New insights into the roles of the <i>FOXO3</i> and <i>P27Kip1</i> genes in signaling pathways

description: <b>Background:</b> The forkhead box O3 (FOXO3) and p27Kip1 are two important genes in breast cancer progression. In the present study we analyzed the effect of simultaneous FOXO3 silencing and p27Kip1 activation on breast cancer cell survival and the potential targets of these changes in cancer molecular pathways. <b>Materials and methods:</b> The present study involved the cloning of <i>FOXO3a</i> shRNA and <i>p27Kip1</i> genes under the control of the bidirectional survivin promoter to down- and up-regulate <i>FOXO3</i> and <i>p27Kip1</i> genes, respectively. After transfection of the recombinant expression vector into the breast cancer cell line, the inhibition of cell growth was assessed by MTS and flow cytometry assays. Following the extraction of total mRNA and protein, the expression of target genes was evaluated by qPCR and Western blotting in both treated and untreated cell lines. Then, the downstream protein responses were examined by 2 D electrophoresis. The differentially expressed proteins were also identified by mass spectrometry. <b>Results:</b> Rates of cell proliferation were significantly inhibited in the transfected cell line 72 h post-transfection. Proteomic profiling of the cell line resulted in the identification of seven novel protein markers in breast cancer responsive to these changes in expression of <i>FOXO3</i> and <i>p27Kip1</i>. The changes in expression of these markers suggested that certain signaling pathways contribute to the development of breast cancer. <b>Conclusion:</b> Simultaneous silencing of <i>FOXO3</i> and activation of <i>p27Kip1</i> in MDA-MB-231 cells caused alterations in the expression level of several genes involved in apoptosis, cell proliferation, cell cycle control, tissue invasion, drug resistance, and metastasis. It seems that the identified genes might serve as useful biomarkers for breast cancer.
DOI: 10.6084/m9.figshare.8858894
title: A health risk for consumers: the presence of adulterated food supplements in the Netherlands

description: The use of food supplements is increasing. They are marketed as beneficial for health, well-being, physical or mental condition and performance, or to prevent diseases. Producers add synthetic compounds or illicit herbal material to food supplements to claim desired effects. Claims made to support marketing without scientific evidence are, however, illegal. Intake of adulterated food supplements may lead to serious adverse effects. The aim of this paper is to report the results of analyses of (adulterated) food supplements conducted by the Netherlands Food and Consumer Product Safety Authority between October 2013 and October 2018. In total, 416 supplements were analysed of which 264 (64%) contained one or more pharmacological active substances or plant toxins, such as caffeine, synephrine, sildenafil, icariin, sibutramine, higenamine, hordenine, phenethylamine, methylsynephrine, DMAA, phenolphthalein, octopamine and ephedrine. When compared to dose levels that are considered safe, daily doses of the substances in the food supplements were sometimes much higher, causing a risk for consumers who are unaware of the presence of these pharmacologically active substances. In many cases, neither food nor medicines legislation (easily) enables enforcement actions. This means that some products containing pharmacologically active substances (i.e. synthetic medicines and their illicit analogues), stay available on the market. An undesirable situation because for many of these substances no detailed toxicity data are available.
DOI: 10.6084/m9.figshare.8858951.v1
title: New insights into the roles of the <i>FOXO3</i> and <i>P27Kip1</i> genes in signaling pathways

description: <b>Background:</b> The forkhead box O3 (FOXO3) and p27Kip1 are two important genes in breast cancer progression. In the present study we analyzed the effect of simultaneous FOXO3 silencing and p27Kip1 activation on breast cancer cell survival and the potential targets of these changes in cancer molecular pathways. <b>Materials and methods:</b> The present study involved the cloning of <i>FOXO3a</i> shRNA and <i>p27Kip1</i> genes under the control of the bidirectional survivin promoter to down- and up-regulate <i>FOXO3</i> and <i>p27Kip1</i> genes, respectively. After transfection of the recombinant expression vector into the breast cancer cell line, the inhibition of cell growth was assessed by MTS and flow cytometry assays. Following the extraction of total mRNA and protein, the expression of target genes was evaluated by qPCR and Western blotting in both treated and untreated cell lines. Then, the downstream protein responses were examined by 2 D electrophoresis. The differentially expressed proteins were also identified by mass spectrometry. <b>Results:</b> Rates of cell proliferation were significantly inhibited in the transfected cell line 72 h post-transfection. Proteomic profiling of the cell line resulted in the identification of seven novel protein markers in breast cancer responsive to these changes in expression of <i>FOXO3</i> and <i>p27Kip1</i>. The changes in expression of these markers suggested that certain signaling pathways contribute to the development of breast cancer. <b>Conclusion:</b> Simultaneous silencing of <i>FOXO3</i> and activation of <i>p27Kip1</i> in MDA-MB-231 cells caused alterations in the expression level of several genes involved in apoptosis, cell proliferation, cell cycle control, tissue invasion, drug resistance, and metastasis. It seems that the identified genes might serve as useful biomarkers for breast cancer.
DOI: 10.6084/m9.figshare.8858888
title: Figure 3 - data

description: Raw data for immunocytochemistry quantification of OCT4/RGECO staining in hiPSCs and cardiac alpha actining/RGECO staining in hiPSC-CMs
DOI: 10.6084/m9.figshare.8859152.v2
title: ITdataset.dta

description: Dataset for a paper submitted to Review of Development Economics (titled Inflation targeting in low-income countries: Does IT work?)
DOI: 10.6084/m9.figshare.8858894.v2
title: A health risk for consumers: the presence of adulterated food supplements in the Netherlands

description: The use of food supplements is increasing. They are marketed as beneficial for health, well-being, physical or mental condition and performance, or to prevent diseases. Producers add synthetic compounds or illicit herbal material to food supplements to claim desired effects. Claims made to support marketing without scientific evidence are, however, illegal. Intake of adulterated food supplements may lead to serious adverse effects. The aim of this paper is to report the results of analyses of (adulterated) food supplements conducted by the Netherlands Food and Consumer Product Safety Authority between October 2013 and October 2018. In total, 416 supplements were analysed of which 264 (64%) contained one or more pharmacological active substances or plant toxins, such as caffeine, synephrine, sildenafil, icariin, sibutramine, higenamine, hordenine, phenethylamine, methylsynephrine, DMAA, phenolphthalein, octopamine and ephedrine. When compared to dose levels that are considered safe, daily doses of the substances in the food supplements were sometimes much higher, causing a risk for consumers who are unaware of the presence of these pharmacologically active substances. In many cases, neither food nor medicines legislation (easily) enables enforcement actions. This means that some products containing pharmacologically active substances (i.e. synthetic medicines and their illicit analogues), stay available on the market. An undesirable situation because for many of these substances no detailed toxicity data are available.
DOI: 10.6084/m9.figshare.8859152.v4
title: ITdataset

description: Dataset for "Inflation targeting in low-income countries: Does IT work?", by Morozumi, Bleaney, and Mumuni, published at Review of Development Economics. ITdataset_1 (for Tables 2,3,and 5 of the paper), ITdataset_2 (Table 4), and ITdataset_3 (Tables 6, 7, 8 and 9)
DOI: 10.6084/m9.figshare.8858888.v2
title: Figure 3 - data

description: Raw data for immunocytochemistry quantification of OCT4/RGECO staining in hiPSCs and cardiac alpha actining/RGECO staining in hiPSC-CMs